<unk>  refers to any of several types of malignant growths of the urinary<unk> .<unk>  may be classified according to cell types into several subtypes: transitional cell carcinomas, squamous cell carcinomas, adenocarcinomas, small cell carcinoma, lymphoma, and sarcoma. The prevalence of<unk>  is approximately 130.5 per 100,000 individuals in the United States. Males are more commonly affected with<unk>  than females. Common risk factors in the development of<unk>  are smoking, occupational exposure to chemicals, chronic<unk>  irritation, chemotherapy, radiation therapy, arsenic, personal history of<unk>  in the urinary tract, congenital<unk>  anomalies, and aristolochic acids. The most common symptoms of<unk>  include hematuria, urinary frequency , urinary urgency, difficulty urinating, and dysuria. Common complications of<unk>  include metastasis, anemia, hydronephrosis, urethral stricture, and urinary incontinence. The predominant therapy for<unk>  is surgical resection. Adjunctive chemotherapy, radiation therapy, and immunotherapy may be required. Prognosis is generally good, and the 5-year survival rate is approximately 77.4%. The prognosis varies with the stages of tumor; carcinoma in situ have the most favorable prognosis.
Bladder cancer
Urethral cancer
Ureteral cancer
Cystitis
Prostate cancer
Pyonephrosis
Pyelonephritis
Interstitial cystitis